European Commission approves BASF acquisition of Cognis

Published: 1-Dec-2010
Ingredients Finance

Transaction has now received approval from all relevant competition authorities


The European Commission has approved BASF‘s acquisition of Cognis, subject to the divestiture of businesses that accounted for sales of less than €100 million, which is less than 3% of Cognis’ total sales.

In addition, the Chinese authorities have also approved the acquisition. The transaction has now received approval from all relevant competition authorities and is expected to close in the first half of December 2010.

BASF has committed to the European Commission to divest the following businesses and assets located at Cognis’s site in Hythe, UK:

  • the Cognis hydroxy methacrylates business
  • the Cognis multifunctional methacrylates (MFM) and adducts business, and
  • plants for the manufacture of polyalkylene glycols (PAG) and PAG-based lubricants. BASF will retain the business including the customer base and intellectual property rights and will receive PAG and PAG-based lubricants manufactured at Hythe through a toll manufacturing agreement. BASF will grant a license for the manufacture of these products to the purchaser of the plants.

BASF reached agreement in June 2010 to acquire the speciality chemicals company for an equity purchase price of €700m. Including net financial debt and pension obligations, the enterprise value of the transaction is €3.1bn.

  • Companies:
  • BASF Personal Care and Nutrition GmbH
See more

You may also like

Ingredients

BASF opens US GMP Solution Centre in Michigan

Read more
Catered towards its biopharma and small molecule customers, the site will provide excipients and bioprocessing ingredients to the US market

Trending Articles

  1. Almac expands bioavailability capabilities to address a critical need in drug development Almac Group has completed a multimillion-pound expansion of its bioavailability enhancement capabilities at its facility in Charnwood, UK
  2. FDA makes groundbreaking decision to waive clinical efficiency studies for monoclonal antibody biosimilars The University of Illinois secured the first-ever FDA acceptance to waive clinical efficiency studies (CESs) for the biological drugs
  3. Fidia Farmaceutici enters the UK market with the acquisition of Altacor Marking another significant milestone in its ongoing international expansion, the company enters the rapidly growing UK ophthalmology market, a key therapeutic area for the group
  4. Rousselot Rousselot is a global leader of gelatin and collagen-based solutions, serving the food, health & nutrition, biomedical, and pharmaceutical sectors. With our advanced Science & Innovation team, we unlock the secrets of the collagen molecule to create products that meet the highest standards of safety and quality. Through our state-of-the-art operations and extensive technical and formulation expertise, we help our customers achieve their goals, create world-class products, and we “Reach further together”. Rousselot is Darling’s Ingredients Health Brand.
  5. Debunking the myths of HPMC adoption Adopting new products, formulations and ways of working can be a challenge for industries as regulated as pharmaceuticals, writes Dr Subhashis Chakraborty, General Manager, Head of Global Product Management, at ACG Capsules

Upcoming event

Enhancing probiotic stability through smarter formulation and packaging strategies

18 September 2025 | Virtual See all

You may also like

Ingredients

BASF opens US GMP Solution Centre in Michigan

Catered towards its biopharma and small molecule customers, the site will provide excipients and bioprocessing ingredients to the US market
Ingredients

Five key takeaways from LogiChem EU 2019

Having recently attended the LogiChem EU 2019 event in Amsterdam, the Netherlands, LLamasoft's Dr Madhav Durbha shares his insights from the chemical industry’s supply chain community
Ingredients

BASF completes acquisition of Chemetall

BASF has completed its acquisition of Albemarle’s global surface treatment business, Chemetall
Ingredients

BASF inaugurates new PVP production facility in Shanghai, China

Will produce PVP K30 powder used as a base for pharma excipients and cosmetics
Ingredients

Colorcon to purchase BASF’s Kollicoat IR coating system product line

The two firms will also further their cooperation to offer superior functional coatings for pharmaceutical tablets
Ingredients

BASF introduces Kollicoat MAE 100-55 for formulation of enteric film coatings

Easier handling due to dust-free material
Manufacturing

BASF establishes speciality amine production plant in Ludwigshafen

BASF’s Intermediates division develops, produces and markets more than 700 intermediates, including amines, diols, polyalcohols and acids
Subscribe now